Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 22, 2024 21:09 ET | Source: Robbins LLP

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against AlloVir, Inc. (ALVR)

AlloVir, Inc. (ALVR) Allegedly Misled Investors Regarding Efficacy of its posoleucel Phase 3 Studies
October 11, 2021 19:52 ET | Source: Portnoy Law

Allogene Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

LOS ANGELES, Oct. 11, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Allogene Therapeutics, Inc. ("Therapeutics" or the "Company") (NASDAQ: ALLO) investors that the firm has initiated an...